{"organizations": [], "uuid": "6fb861251005a05fa844331d57cebbd0a2b9fbfb", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180222.html", "section_title": "Archive News &amp; Video for Thursday, 22 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-lexicon-pharmaceuticals-q4-loss-pe/brief-lexicon-pharmaceuticals-q4-loss-per-share-0-27-idUSASB0C6Y5", "country": "US", "domain_rank": 408, "title": "BRIEF-Lexicon Pharmaceuticals Q4 Loss Per Share $0.27", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.698, "site_type": "news", "published": "2018-02-22T20:18:00.000+02:00", "replies_count": 0, "uuid": "6fb861251005a05fa844331d57cebbd0a2b9fbfb"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-lexicon-pharmaceuticals-q4-loss-pe/brief-lexicon-pharmaceuticals-q4-loss-per-share-0-27-idUSASB0C6Y5", "ord_in_thread": 0, "title": "BRIEF-Lexicon Pharmaceuticals Q4 Loss Per Share $0.27", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "lexicon pharmaceuticals inc", "sentiment": "negative"}, {"name": "brief-lexicon pharmaceuticals", "sentiment": "negative"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 22 (Reuters) - Lexicon Pharmaceuticals Inc:\n* LEXICON PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE\n* Q4 LOSS PER SHARE $0.27 * REVENUES FOR Q4 INCREASED 43% FROM PRIOR-YEAR PERIOD TO $33.0 MILLION\n* Q4 EARNINGS PER SHARE VIEW $-0.41, REVENUE VIEW $30.0 MILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-22T20:18:00.000+02:00", "crawled": "2018-02-23T15:54:52.009+02:00", "highlightTitle": ""}